This application is directed to inhibitors of dynamin-l-like protein (Drpl) represented by the following structural formula (I): and methods for their use, such as to treat one or more DRPl-related diseases.
该申请涉及以下结构公式(I)表示的dynamin-l样蛋白(Drpl)的
抑制剂:以及它们的使用方法,例如用于治疗一种或多种与DRPl相关的疾病。